In vitro and in vivo Study on Glioma Treatment Enhancement by Combining Temozolomide with Calycosin and Formononetin
Bibliographic Data
| ID | 14740817 |
|---|---|
| Authors | Qi Ni (0000-0002-7514-221X, Nanjing Medical University), Yani Fan (0000-0002-0806-4813, Nanjing Medical University), Xiong Zhang (0000-0001-5173-6470, Nanjing Medical University), Hongwei Fan (0000-0002-9891-0568, Nanjing Medical University, corresponding author), Yingbin Li (0000-0002-0207-8667, Second Affiliated Hospital of Nanjing Medical University, corresponding author) |
| Year | 2019 |
| Volume | 242 |
| Pages | 111699 |
| Publication date | 2019-10-01 |
| Peer Reviewed | Yes |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Journal of Ethnopharmacology (JOURNAL) |
| Journal identifiers | ISSN: 0378-8741 • E-ISSN: 1872-7573 |
| Publisher | Elsevier BV (PUBLISHER) |
| DOI | 10.1016/j.jep.2019.01.023 |
| PMID | 31005632 |
| OpenAlex | W2938881653 |
| Language | EN |
| Citations received | 2 |
| References cited | 23 |
This study has identified that calycosin and FMN can increase the treatment effect of TMZ in vitro and in vivo. These attractive features substantially broadened the application range of TMZ as a glioma treatment medicine
Apoptosis · Biology · Calycosin · Cell growth · Formononetin · Genistein · Glioma · In vivo · MTT assay · Programmed cell death · Propidium iodide · Temozolomide · Western blot · Bioactive Natural Diterpenoids Research · Chemistry · Flavonoids in Medical Research · Medicine · Traditional Chinese Medicine Analysis · Biochemistry · Cancer Research · Internal Medicine · Molecular Biology · Pharmacology
| Unique citing works | 2 |
|---|---|
| Citations per year | 0,4 |
| Citation span | 2021 - 2024 (4) |
| Citation velocity | recent |
| Highly cited | No |
| Citation types | Neutral: 2 |